Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study of BI-1607, Ipilimumab, and Pembrolizumab for Patients with Advanced Melanoma
GermanyStudy on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa
BulgariaStudy on the Effects of Deucravacitinib for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on Long-Term Safety of Briquilimab for Patients with Chronic Urticaria
GermanyStudy on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
BulgariaStudy on the Effects of IDP-122 Lotion for Children with Moderate to Severe Plaque Psoriasis
PolandStudy of Retifanlimab Combined with Carboplatin, Cisplatin and Etoposide Before Surgery in Patients with Resectable Merkel Cell Carcinoma
ItalyStudy on the Effectiveness of Dupilumab Injections for Itch Relief in Adults with Lichen Simplex Chronicus
BelgiumStudy on Rigosertib Sodium for Patients with Recessive Dystrophic Epidermolysis Bullosa and Advanced Squamous Cell Carcinoma
AustriaStudy of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer
FranceStudy of HPV vaccine to prevent recurrence of External Genital Warts in previously cured patients: Comparing Human Papillomavirus vaccine versus placebo
FranceStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
BelgiumThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
